- Home
- TACO vs LAB Comparison
TACO vs LAB Comparison
Compare TACO & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TACO
- LAB
- Stock Information
- Founded
- TACO 2024
- LAB 1999
- Country
- TACO United States
- LAB United States
- Employees
- TACO N/A
- LAB N/A
- Industry
- TACO Blank Checks
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- TACO Finance
- LAB Industrials
- Exchange
- TACO Nasdaq
- LAB Nasdaq
- Market Cap
- TACO 389.8M
- LAB 372.1M
- IPO Year
- TACO 2025
- LAB 2011
- Fundamental
- Price
- TACO $10.34
- LAB $1.34
- Analyst Decision
- TACO
- LAB Buy
- Analyst Count
- TACO 0
- LAB 2
- Target Price
- TACO N/A
- LAB $2.50
- AVG Volume (30 Days)
- TACO 71.6K
- LAB 2.8M
- Earning Date
- TACO 01-01-0001
- LAB 07-30-2025
- Dividend Yield
- TACO N/A
- LAB N/A
- EPS Growth
- TACO N/A
- LAB N/A
- EPS
- TACO N/A
- LAB N/A
- Revenue
- TACO N/A
- LAB $169,687,000.00
- Revenue This Year
- TACO N/A
- LAB N/A
- Revenue Next Year
- TACO N/A
- LAB $12.18
- P/E Ratio
- TACO N/A
- LAB N/A
- Revenue Growth
- TACO N/A
- LAB 33.86
- 52 Week Low
- TACO $10.10
- LAB $0.92
- 52 Week High
- TACO $11.26
- LAB $2.41
- Technical
- Relative Strength Index (RSI)
- TACO N/A
- LAB 58.76
- Support Level
- TACO N/A
- LAB $1.27
- Resistance Level
- TACO N/A
- LAB $1.41
- Average True Range (ATR)
- TACO 0.00
- LAB 0.11
- MACD
- TACO 0.00
- LAB 0.01
- Stochastic Oscillator
- TACO 0.00
- LAB 50.00
About TACO Berto Acquisition Corp. Ordinary Shares
Berto Acquisition Corp is a blank check company.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.